Balestri, R, Odorici, G, Magnano, M, Gisondi, P, Bellinato, F, Ribero, S, Dapavo, P, Mastorino, L, Burlando, M, Cozzani, E, Bernardini, N, Potenza, C, Balato, A, Caccavale, S, Di, LV, Peccerillo, F, Megna, M, Campanati, A, Loconsole, F, Mortato, E, Trovato, E, Mantovani, L
, Caldarola, G, De Simone, C, Falco, GM, Narcisi, A, Alfano, A, Galluzzo, M, Fico, A, Pezzolo, E, Prignano, F, Di, CA, Loi, C, Satolli, F, Musumeci, ML, Ortega, R, Errichetti, E, Dini, V, Michelucci, A, Amerio, P, Carugno, A, Tabanelli, M, Conti, A, Guarneri, C, Bardazzi, F & Rech, G 2025, '
Switching to brodalumab after failure of IL-17A inhibitors in psoriatic patients: A real-life multicentre study',
Journal of the European Academy of Dermatology and Venereology, n. n/a, pagg. N/A-N/A.
https://doi.org/10.1111/jdv.20774